Cited by 105Opioid Use Disorder TreatmentMindfulness and Compassion InterventionsSubstance Abuse Treatment and Outcomes

Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial

Garland, Eric L., Hanley, Adam W., Kline, Anna, Cooperman, Nina A.·2019·Drug and Alcohol Dependence

Abstract

Background Methadone maintenance therapy (MMT) is an efficacious form of medication assisted treatment for opioid use disorder (OUD), yet many individuals on MMT relapse. Chronic pain and deficits in positive affective response to natural rewards may result in dysphoria that fuels opioid craving and promotes relapse. As such, behavioral therapies that ameliorate chronic pain and enhance positive affect may serve as useful adjuncts to MMT. This analysis of ecological momentary assessment (EMA) data from a Stage 1 randomized clinical trial examined effects of Mindfulness-Oriented Recovery Enhancement (MORE) on opioid craving, pain, and positive affective state.Methods Participants with OUD and chronic pain (N = 30) were randomized to 8 weeks of MORE or treatment as usual (TAU). Across 8 weeks of treatment, participants completed up to 112 random EMA measures of craving, pain, and affect, as well as event-contingent craving ratings. Multilevel models examined the effects of MORE on craving, pain, and affect, as well as the association between positive affect and craving.Results EMA showed significantly greater improvements in craving, pain unpleasantness, stress, and positive affect for participants in MORE than for participants in TAU. Participants in MORE reported having nearly 1.3 times greater self-control over craving than those in TAU. Further, positive affect was associated with reduced craving, an association that was significantly stronger among participants in MORE than TAU.Conclusion MORE may be a useful non-pharmacological adjunct among individuals with OUD and chronic pain in MMT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2019.07.007

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of the 4 SUD trials with a short-term follow-up, two out of 4 studies reported statistically significant improvements in pain intensity in the intervention group.

    “Of the 4 trials with a shortterm follow-up, 20,27,28,36 two out of 4 studies reported statistically significant improvements in pain intensity in the intervention group, 27,36”

    From The Effectiveness of Interventions for Improving Chronic Pain Symptoms Among People With Mental Illness: A Systematic Review (2024) · cites this paper as [28]

    The Results section (“Craving, Pain, and Affective State”; page unavailable) reports a statistically significant decrease in pain unpleasantness for MORE compared with usual treatment, but explicitly says the decrease in pain intensity was not significant (p>.10). The paper therefore does not support counting this trial among those with a statistically significant improvement in pain intensity. (LLM, conf=0.89)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Mindfulness has shown promise as an acceptable behavioral treatment for OUD comorbidities such as chronic pain and anxiety when used with buprenorphine/naloxone, even in primary care.

    “Mindfulness has shown promise as an acceptable behavioral treatment for OUD comorbidities such as chronic pain and anxiety when employed in conjunction with buprenorphine/naloxone treatment, even within primary care 23,24.”

    From Effects of a trauma-informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof-of-concept study (2023) · cites this paper as [23]

    The Results (Craving, Pain, and Affective State; page unavailable) report reduced pain unpleasantness and stress with Mindfulness-Oriented Recovery Enhancement, supporting its promise as an adjunctive behavioral treatment. But the Method (Participants and Procedure; page unavailable) places the trial in methadone-maintenance clinics, not buprenorphine/naloxone treatment or primary care. The cited passages do not establish acceptability or an effect on anxiety specifically. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Reduced opioid craving post-treatment was found in 3 of those 4 SUD trials.

    “All 4 trials included drug screens, and reduced opioid craving post-treatment was also found in 3. 20,27,28”

    From The Effectiveness of Interventions for Improving Chronic Pain Symptoms Among People With Mental Illness: A Systematic Review (2024) · cites this paper as [28]

    The Results (Craving, page unavailable) report significantly greater decreases in opioid wanting and urges with MORE than with treatment as usual during the eight-week intervention. The Discussion (page unavailable) says the study could not assess whether those changes lasted beyond treatment, so it does not establish a post-treatment reduction. This single trial also cannot establish the citing document’s count of three trials. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Among the 10 SUD trials, two evaluated a CBT-based intervention, three included a MBI (one of which involved integrated MBI and ACT), two examined a MCI, one included a pharmacological-based treatment, and 2 involved a body-based intervention.

    “Two trials eval­ uated a CBT-based intervention, 20,23 three included a MBI, 27,28,30 one of which involved integrated MBI and ACT, 30 two examined a MCI, 39,40 one included a phar­ macological-based treatment, 45 and 2 involved a bodybased intervention. 35,36”
  • Six trials evaluated an MBI, mostly among patients with OUD.

    “In total, 6 trials evaluated an MBI, mostly among pa­ tients with OUD, 24-30”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Garland EL, 2013 Mindfulness-oriented recovery enhancement for addiction, stress, and pain. NASW Press, Washington, D.C.

Cited by

Sorted by citations

Authors
Garland, E. L., Hanley, A. W., Kline, A., & Cooperman, N. A.
Affiliations
  • University of Utah (US)
  • Rutgers, The State University of New Jersey (US)
Corresponding author
Garland, Eric L.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2019-10
Volume
203
Pages
61-65
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2965466047
Cited by
105
References
33
Citations by year
2026: 16 · 2025: 14 · 2024: 17 · 2023: 17 · 2022: 17 · 2021: 14 · 2020: 8 · 2019: 2
FWCI
9.38
Type
journal article
Language
en
Open access
closed
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Center for Complementary and Integrative Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
Mindfulness-Oriented Recovery Enhancement, opioid craving, opioid use disorder, chronic pain, methadone maintenance treatment, medication-assisted treatment, positive affect, pain unpleasantness, stress, relapse prevention
MeSH terms
Ecological Momentary Assessment, Adolescent, Adult, Affect, Analgesics, Opioid, Combined Modality Therapy, Female, Humans, Male, Methadone, Middle Aged, Opioid-Related Disorders, Young Adult, Opiate Substitution Treatment, Chronic Pain, Mindfulness, Craving

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review